Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Florio is a Germany-based digital healthcare company focused on software medical devices for people living with rare diseases. Founded in 2019 in Munich, the company develops and operates patient-facing apps and clinician dashboards that support monitoring, data capture, and personalized care. Its commercial product set includes solutions for hemophilia, immune thrombocytopenia, paroxysmal nocturnal hemoglobinuria, and complement-mediated kidney diseases such as C3G and IC-MPGN. Florio operates as an independently run subsidiary of Sobi and appears positioned as a digital companion and real-world data enablement business rather than a drug developer. The company combines medical affairs, software engineering, regulatory, quality, and data privacy capabilities to build regulated digital products for rare-disease care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Florio.